varisacumab
Varisacumab is an investigational monoclonal antibody that binds to the vascular endothelial growth factor A (VEGF-A) and selectively inhibits the activation of VEGF receptor 2 (VEGFR-2). VEGF-A modulates both tumor angiogenesis and immune cell trafficking.
varisacumab

Varisacumab is an investigational monoclonal antibody that binds to the vascular endothelial growth factor A (VEGF-A) and selectively inhibits the activation of VEGF receptor 2 (VEGFR-2). VEGF-A modulates both tumor angiogenesis and immune cell trafficking.